logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Merrill J. Egorin

University of Pittsburgh

71H指数
550论文数
2.2W被引数
收录论文 76
发表时间
logo
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) (vol 143, pg 573, 2019)
errJOURNAL OF NEURO-ONCOLOGY
IF3.1
err2019-06-05
err1
errOAAI
errJaeckle, Kurt A.; Anderson, S. K.; Twohy, Erin L.; Dixon, Jesse G.; Giannini, Caterina; Jenkins, Robert; Egorin, Merrill J.; Sarkaria, Jann N.; Brown, Paul D.; Flynn, P. J.; Schwerkoske, John; Buckner, Jan C.; Galanis, Evanthia
err分享
err收藏
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)
errJOURNAL OF NEURO-ONCOLOGY
IF3.1
err2019-05-22
err10
errOAAI
errJaeckle, Kurt A.; Anderson, S. K.; Twohy, Erin L.; Dixon, Jesse G.; Giannini, Caterina; Jenkins, Robert; Egorin, Merrill J.; Sarkaria, Jann N.; Brown, Paul D.; Flynn, P. J.; Schwerkoske, John; Buckner, Jan C.; Galanis, Evanthia
err分享
err收藏
Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis
errANNALS OF ONCOLOGY
IF65.4
err2013-04-01
err57
errOAAI
errTawbi, H. A.; Beumer, J. H.; Tarhini, A. A.; Moschos, S.; Buch, S. C.; Egorin, M. J.; Lin, Y.; Christner, S.; Kirkwood, J. M.
err分享
err收藏
Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer
errBRITISH JOURNAL OF CANCER
IF6.8
err2012-07-17
err20
errOAAI
errNabhan, C.; Villines, D.; Valdez, T. V.; Tolzien, K.; Lestingi, T. M.; Bitran, J. D.; Christner, S. M.; Egorin, M. J.; Beumer, J. H.
err分享
err收藏
Renal dysfunction in a renal transplant patient treated concurrently with cyclosporine and imatinib
errINVESTIGATIONAL NEW DRUGS
IF2.7
err2011-11-25
err13
PREAI
errMulder, Karen E.; Egorin, Merrill J.; Sawyer, Michael B.
err分享
err收藏
Modulation of DMS612 (BEN) pharmacokinetics and metabolism in mice by disulfiram, and aldehyde dehydrogenase inhibitor
errCANCER RESEARCH
IF16.6
err2011-04-01
err0
PREAI
errParise, Robert A.; Beumer, Jan; Clausen, Dana; Egorin, Merrill; Covey, Joseph; Eiseman, Julie
err分享
err收藏
Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas
errCLINICAL CANCER RESEARCH
IF10.2
err2011-03-15
err90
errOAAI
errStathis, Anastasios; Hotte, Sebastien J.; Chen, Eric X.; Hirte, Holger W.; Oza, Amit M.; Moretto, Patricia; Webster, Sheila; Laughlin, Anne; Stayner, Lee-Anne; McGill, Shauna; Wang, Lisa; Zhang, Wen-jiang; Espinoza-Delgado, Igor; Holleran, Julianne L.; Egorin, Merrill J.; Siu, Lillian L.
err分享
err收藏
In Vitro Cytotoxicity and In Vivo Efficacy, Pharmacokinetics, and Metabolism of 10074-G5, a Novel Small-Molecule Inhibitor of c-Myc/Max Dimerization
errJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
IF3.8
err2010-12-01
err117
errOAAI
errClausen, Dana M.; Guo, Jianxia; Parise, Robert A.; Beumer, Jan H.; Egorin, Merrill J.; Lazo, John S.; Prochownik, Edward V.; Eiseman, Julie L.
err分享
err收藏
Subconjunctival Carboplatin and Systemic Topotecan Treatment in Preclinical Models of Retinoblastoma
errCANCER
IF5.1
err2010-09-03
err46
errOAAI
errNemeth, Katie M.; Federico, Sara; Carcaboso, Angel M.; Shen, Ying; Schaiquevich, Paula; Zhang, Jiakun; Egorin, Merrill; Stewart, Clinton; Dyer, Michael A.
err分享
err收藏
Liquid chromatography-tandem mass spectrometric assay for the quantitation in human plasma of the novel indenoisoquinoline topoisomerase I inhibitors, NSC 743400 and NSC 725776
errJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
IF3.1
err2010-09-01
err14
errOAAI
errHolleran, Julianne L.; Parise, Robert A.; Yellow-Duke, Archibong E.; Egorin, Merrill J.; Eiseman, Julie L.; Covey, Joseph M.; Beumer, Jan H.
err分享
err收藏
Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies
errINVESTIGATIONAL NEW DRUGS
IF2.7
err2010-08-05
err55
PREAI
errSchneider, Bryan J.; Kalemkerian, Gregory P.; Bradley, Deborah; Smith, David C.; Egorin, Merrill J.; Daignault, Stephanie; Dunn, Rodney; Hussain, Maha
err分享
err收藏
Phase 1 and Pharmacokinetic Study of Everolimus, a Mammalian Target of Rapamycin Inhibitor, in Combination With Docetaxel for Recurrent/Refractory Nonsmall Cell Lung Cancer
errCANCER
IF5.1
err2010-08-04
err35
errOAAI
errRamalingam, Suresh S.; Harvey, R. Donald; Saba, Nabil; Owonikoko, Taofeek K.; Kauh, John; Shin, Dong M.; Sun, Shi-Yong; Strychor, Sandra; Tighiouart, Mourad; Egorin, Merrill J.; Fu, Haian; Khuri, Fadlo R.
err分享
err收藏
A phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignanciesBMS-275183的1期研究，一种新型紫杉醇口服类似物，每天给予晚期恶性肿瘤患者
errINVESTIGATIONAL NEW DRUGS
IF2.7
err2010-08-03
err17
PREAI
errHeath, Elisabeth I.; LoRusso, Patricia; Ramalingam, Suresh S.; Awada, Ahmad; Egorin, Merrill J.; Besse-Hamer, Tatiana; Cardoso, Fatima; Valdivieso, Manuel; Has, Teresa; Alland, Leila; Zhou, Xiaofei; Belani, Chandra P.
err分享
err收藏
A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumors
errINVESTIGATIONAL NEW DRUGS
IF2.7
err2010-07-27
err18
PREAI
errJain, Rajul K.; Trump, Donald L.; Egorin, Merrill J.; Fernandez, Manuel; Johnson, Candace S.; Ramanathan, Ramesh K.
err分享
err收藏
Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of the Combination of Sorafenib and Tanespimycin
errCLINICAL CANCER RESEARCH
IF10.2
err2010-07-14
err53
errOAAI
errVaishampayan, Ulka N.; Burger, Angelika M.; Sausville, Edward A.; Heilbrun, Lance K.; Li, Jing; Horiba, M. Naomi; Egorin, Merrill J.; Ivy, Percy; Pacey, Simon; LoRusso, Patricia M.
err分享
err收藏
A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Two Schedules of Vorinostat in Combination with 5-Fluorouracil and Leucovorin in Patients with Refractory Solid Tumors
errCLINICAL CANCER RESEARCH
IF10.2
err2010-07-14
err35
errOAAI
errFakih, Marwan G.; Fetterly, Gerald; Egorin, Merrill J.; Muindi, Josephia R.; Espinoza-Delgado, Igor; Zwiebel, James A.; Litwin, Alan; Holleran, Julianne L.; Wang, Kangsheng; Diasio, Robert B.
err分享
err收藏
Enhanced cytotoxicity of carboplatin and paclitaxel (CP) by vorinostat (SAHA), a histone deacetylase (HDAC) inhibitor, in melanoma cell lines
errCANCER RESEARCH
IF16.6
err2010-04-01
err0
PREAI
errTawbi, Hussein; Lin, Ying-Chih; Villaruz, Liza; Egorin, Merrill J.; Beumer, Jan H.; Kirkwood, John M.; Sobol, Robert W.
err分享
err收藏
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)
errNEURO-ONCOLOGY
IF13.4
err2009-12-01
err121
errOAAI
errWen, Patrick Y.; Yung, W. K. Alfred; Lamborn, Kathleen R.; Norden, Andrew D.; Cloughesy, Timothy F.; Abrey, Lauren E.; Fine, Howard A.; Chang, Susan M.; Robins, H. Ian; Fink, Karen; DeAngelis, Lisa M.; Mehta, Minesh; Di Tomaso, Emmanuelle; Drappatz, Jan; Kesari, Santosh; Ligon, Keith L.; Aldape, Ken; Jain, Rakesh K.; Stiles, Charles D.; Egorin, Merrill J.; Prados, Michael D.
err分享
err收藏
Embryonic stem cells lacking the epigenetic regulator Cfp1 are hypersensitive to DNA-damaging agents and exhibit decreased Ape1/Ref-1 protein expression and endonuclease activity
errDNA REPAIR
IF2.7
err2009-12-01
err3
errOAAI
errTate, Courtney M.; Fishel, Melissa L.; Holleran, Julianne L.; Egorin, Merrill J.; Skalnik, David G.
err分享
err收藏
Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
errBRITISH JOURNAL OF CANCER
IF6.8
err2009-09-08
err147
errOAAI
errMunster, P. N.; Marchion, D.; Thomas, S.; Egorin, M.; Minton, S.; Springett, G.; Lee, J-H; Simon, G.; Chiappori, A.; Sullivan, D.; Daud, A.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
J
Jörge E. Cortes
H 指数: 179 · 论文数: 3.6K
P
Patrick Y. Wen
H 指数: 145 · 论文数: 1.9K
M
Minesh P. Mehta
H 指数: 138 · 论文数: 2.2K
J
John M. Kirkwood
H 指数: 137 · 论文数: 1.3K
R
Roger E. McLendon
H 指数: 131 · 论文数: 734
查看更多